Emergency Medicine Specialty Recertification Literature Study: Module 1A-B (Cert #L259070)

ACPE Numbers: Various – see listing below
Content Release Date: 07/16/2025
Expiration Dates: 07/14/2026
Activity Type: Application-based
CE Credits: 10 hours (BPS and ACPE)
Activity Fee: $65 (ASHP member); $120 (non-member)

Activity Overview

The Literature Study Module is intended for board certified pharmacists in need of recertification credit and is designed based on the content outline developed by the Board of Pharmacy Specialties (BPS). This module consists of 2 online home study activities (see table below). Each activity is designed to assess the learners’ ability to analyze and apply peer-selected contemporary articles to practice.

Module 1A – Guidelines, Consensus Reports, and Policy: This module focuses on recent guidelines, consensus reports and policy publications. Topics include antibiotic prophylaxis in injury, hyperglycemic crisis, hyperemesis syndrome, and hypertension.

Module 1B – Clinical Updates and Practice Management: This module includes a variety of therapeutic areas. Topics include analgesia in traumatic pain, antibiotics in pediatric sepsis, intracerebral hemorrhage, and nebulized medications.

Learners will be required to review the content and complete the associated online assessments. The learner must be able to correctly answer the questions based upon their interpretation of the content, as well as “baseline specialty specific knowledge and/or easily retrievable information.” For purposes of this Literature Study, “baseline specialty specific knowledge and/or easily retrievable information” is defined as product labeling and well-established standards of practice in the specialty practice.

These activities are part of the ASHP and ACCP professional development program for BCEMP recertification approved by the BPS.

Accreditation

Target Audience

Recertification Credit

Board certified pharmacists are eligible to receive up to 10 contact hours of recertification credit for completing this course. To earn recertification credit, learners must review the course content and successfully complete the online assessments by the deadline.

ASHP provides an opportunity for remediation. Participants who are unsuccessful with the first assessment attempt may take a second assessment. The second assessment is included at no additional cost.

ASHP and ACCP are approved by BPS as providers for the recertification of BCEMP.

Learning Activity	ACPE Number	Contact Hours (ACPE and BPS)	Assessment Pass Point
Module 1A: Guidelines, Consensus Reports, and Policy	0204-9999-25-920-H01-P	5.0	76%
Module 1B: Clinical Updates and Practice Management	0204-9999-25-921-H01-P	5.0	76%

Articles and Learning Objectives

Module 1A: Guidelines, Consensus Reports, and Policy
ACPE #: 0204-9999-25-920-H01-P

This module focuses on recent guidelines, consensus reports and policy publications. Topics include antibiotic prophylaxis in injury, hyperglycemic crisis, hyperemesis syndrome, and hypertension.

Appelbaum RD, Farrell MS, Gelbard RB, et al. Antibiotic prophylaxis in injury: an American Association for the Surgery of Trauma Critical Care Committee clinical consensus document. Trauma Surg Acute Care Open. 2024: 9:e001304

Describe the clinical consensus document from the American Association for the Surgery of Trauma (AAST) Critical Care Committee for the use of antibiotic prophylaxis in patients with traumatic injury
Develop recommendations for the use of antibiotic prophylaxis in adult trauma patients who are at risk for infection because of their injury

Umpierrez GE, Davis GM, ElSayed NA, et al. Hyperglycemic crises in adults with diabetes: a consensus report. Diabetes Care 2024; 47: 1257 - 1275.

Describe the multiorganizational consensus report on hyperglycemic crises in adults with diabetes from the American Diabetes Association (ADA), European Association for the Study of Diabetes (EASD), and other groups
Develop recommendations for the diagnosis, treatment, and prevention of diabetic ketoacidosis (DKA) and hyperglycemic hyperosmolar state (HHS) in adults with diabetes mellitus

Borgundvaag B, Bellolio F, Miles I, et al. Guidelines for Reasonable and Appropriate Care in the Emergency Department (GRACE-4): Alcohol use disorder and cannabinoid hyperemesis syndrome management in the emergency department. Acad Emerg Med. 2024;31(5):425-455. doi:10.1111/acem.14911

Describe the fourth Society for Academic Emergency Medicine (SAEM) Guidelines for Reasonable and Appropriate Care in the Emergency Department (GRACE-4) pertaining to alcohol withdrawal syndrome, alcohol use disorder, and cannabinoid hyperemesis syndrome management
Develop recommendations for the management of alcohol withdrawal syndrome, alcohol use disorder, and cannabinoid hyperemesis syndrome in the emergency department

Bress AP, Anderson TS, Flack JM, et al. The management of elevated blood pressure in the acute care setting: a scientific statement from the American Heart Association. Hypertension 2024; 81(8): e94-106

Describe the scientific statement from the American Heart Association (AHA) for the management of elevated blood pressure in the acute care setting
Develop recommendations for the management of elevated blood pressure in patients in the emergency department and inpatients

Module 1B: Clinical Updates and Practice Management
ACPE #: 0204-9999-25-921-H01-P

This module includes a variety of therapeutic areas. Topics include analgesia in traumatic pain, antibiotics in pediatric sepsis, intracerebral hemorrhage, and nebulized medications.

Le Cornec C, Le Pottier M, Broch H, et al. Ketamine Compared With Morphine for Out-of-Hospital Analgesia for Patients With Traumatic Pain: A Randomized Clinical Trial. JAMA Netw Open. 2024 Jan 2;7(1):e2352844.

Describe the Intravenous Subdissociative-Dose Ketamine Versus Morphine for Prehospital Analgesia (KETAMORPH) study by Le Cornec and colleagues
Develop recommendations for pain relief in adults with out-of-hospital acute traumatic pain

Lane RD, Richardson T, Scott HF, et al. Delays to Antibiotics in the Emergency Department and Risk of Mortality in Children With Sepsis. JAMA Netw Open. 2024;7(6):e2413955.

Describe the study by Lane and colleagues of the relationship between the timing of antibiotic administration and mortality in pediatric patients with sepsis
Develop recommendations for the initiation of antibiotic therapy in pediatric patients with sepsis

Sheth KN, Solomon N, Alhanti B, et al. Time to anticoagulation reversal and outcomes after intracerebral hemorrhage. JAMA Neurol. 2024;81(4):363-372

Describe the cohort study by Sheth and colleagues of time to anticoagulation reversal in patients with intracerebral hemorrhage
Develop recommendations for optimizing outcomes in patients with anticoagulation-associated

Connolly SJ, Sharma M, Cohen AT, et al. Andexanet for Factor Xa inhibitor-associated acute intracerebral hemorrhage. N Engl J Med 2024; 390: 1745 - 1755.

Describe the ANNEXA-I study by Connolly and colleagues of andexanet alfa for acute intracerebral hemorrhage
Develop recommendations for the management of factor Xa inhibitor-associated acute intracerebral hemorrhage

Ruff IM, deHavenon A, Bergman DL, et al. 2024 AHA/ASA performance and quality measures for spontaneous intracerebral hemorrhage: a report from the American Heart Association/American Stroke Association. Stroke 2024; 55: e199-230.

Describe the 2024 American Heart Association (AHA)/American Stroke Association (ASA) performance and quality measures for acute, spontaneous, nontraumatic intracerebral hemorrhage
Develop recommendations for performance and quality measures to use in improving the quality of care for patients with acute, spontaneous, nontraumatic intracerebral hemorrhage

Weant KA, Baum RA, Hile GB, et al. Nebulized medications in the emergency department: a narrative review of nontraditional agents. Am J Health-Syst Pharm 2024; 81: 88 - 105.

Describe nontraditional (novel, noncommercial) aerosolized medications administered by the nebulized route used in the emergency department
Develop recommendations for the administration of nontraditional (novel, noncommercial) aerosolized medications by the nebulized route in the emergency department

Faculty

Full Faculty Bios

Heather Draper, PharmD, BCPS, BCEMP*
Clinical Pharmacy Specialist, Emergency Medicine
Trinity Health Grand Rapids

Lauren Floris, PharmD, BCPS
Clinical Pharmacist
Atrium Health Navicent - The Medical Center

Curtis Geier, PharmD, BCEMP
Emergency Medicine Clinical Pharmacist
San Francisco General Hospital and Trauma Center

Josh Heffren, PharmD, BCPPS
Emergency Medicine Pharmacy Supervisor
Children’s National Hospital

Samantha Luciana, PharmD, BCPS, BCEMP
Clinical Pharmacy Specialist, Emergency Medicine
Bryn Mawr Hospital

Maggie Ma, PharmD, BCEMP
Clinical Pharmacy Specialist, Emergency Medicine
The University of Texas MD Anderson Cancer Center

Megan Musselman, PharmD, MS, BCPS, BCCCP, BCEMP, DPLA, FASHP, FCCP*
Clinical Pharmacy Coordinator - Emergency Medicine Pharmacy Residency
Program Director
North Kansas City Hospital

Heather Tilley, PharmD, BCEMP
Clinical Pharmacy Specialist
The Johns Hopkins Hospital

Kyle Weant, PharmD, BCPS, BCCCP, FCCP
Clinical Adjunct Professor, Emergency Medicine
University of South Carolina College of Pharmacy

David Zimmerman, PharmD, BCCCP, BCEMP, FASHP*
Associate Professor of Pharmacy
Duquesne University School of Pharmacy

* Content Matter Experts

Reviewers

Field Testers

Sam Abid, PharmD, BCPS, BCEMP
Danyel Adams, PharmD, BCEMP
Emily Ankney, PharmD, BCCCP, BCEMP
Zachary Benzio, PharmD, BCPS, BCEMP
Cheri Bertani, PharmD, BCCCP, BCEMP
Michelle Blesso, PharmD, BCPS, BCEMP
Anna Capulong, PharmD, BCPS, BCEMP
Allison Clarke, PharmD, BCEMP, BCPS
Jessica Corio, PharmD, BCEMP
Sarah Creed, PharmD, BCEMP, BCPS
Anna Drury, PharmD, BCEMP
Bryan Gendron, PharmD, BCEMP
Erin Gordon, PharmD, BCEMP
Thomas Gregory, PharmD, BCPS, BCEMP
Brittany Harnicher, PharmD, BCEMP
Stacy Henry, PharmD, BCPS, BCEMP
Lindsay Jacobs, PharmD, MPH, BCCCP, BCEMP
Tara Jawaro, PharmD, BCPS, BCEMP
Rachel Khuc, PharmD, BCPS, BCEMP
Vivian Kum, PharmD, BCEMP
John Littler, PharmD, BCEMP
Montana Mack, PharmD, BCEMP
Andrew McInerney, PharmD, BCEMP
Michele Meadows, PharmD, BCEMP
Alison Merkel, PharmD, BCEMP
Matthew Morrison, PharmD, BCPS, BCEMP
Cody Pitts, PharmD, BCPS, BCEMP
Alyssa Robertson, PharmD, BCPS, BCCCP, BCEMP
Christian Ruiz, PharmD, BCEMP
Kathryn Samai, PharmD, BCEMP
Ravipal Singh, PharmD, BCEMP, BCCP
Lauren Stauffer, PharmD, BCPS, BCEMP
Amanda Vanderwerf, PharmD, BCEMP
Stephanie Wong, PharmD, BCEMP
Abigail Zeiner, PharmD, BCPS, BCEMP

Relevant Financial Relationship Disclosures

In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.

An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.

No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.

As required by the Standards of Integrity and Independence in Accredited Continuing Education, all relevant financial relationships have been mitigated prior to the CPE activity.